Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 133.02
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Basel, Birkhäuser Verlag, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: Schätze & Co., Münnerstadt, KG, Germany
Gr. 8°, Hardcover. Condition: Sehr gut. Ill., 251 S. Sprache: Englisch; sehr gutes Ex. Sprache: Englisch Gewicht in Gramm: 730.
US$ 161.90
Quantity: Over 20 available
Add to basketPaperback. Condition: New. Softcover reprint of the original 1st ed. 1999.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 217.35
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New.
US$ 217.34
Quantity: Over 20 available
Add to basketCondition: New.
Condition: New.
US$ 157.62
Quantity: Over 20 available
Add to basketPaperback. Condition: New. Softcover reprint of the original 1st ed. 1999.
US$ 195.09
Quantity: Over 20 available
Add to basketGebunden. Condition: New.
US$ 195.09
Quantity: Over 20 available
Add to basketKartoniert / Broschiert. Condition: New.
Condition: New. pp. 268.
Taschenbuch. Condition: Neu. Proton Pump Inhibitors | Lars Olbe | Taschenbuch | x | Englisch | 2013 | Birkhäuser | EAN 9783034897778 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Birkhauser Verlag AG, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. This monograph contains a description of the discovery and development of a new antisecretory therapy in the treatment of acid-related diseases: omeprazole, the first pump inhibitor. The pharmacology of different proton pump inhibitors and the pharmaceutic delivery system are reviewed. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MJH; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 244 x 170 x 20. Weight in Grams: 730. . 1999. Hardback. . . . .
Seller: Mispah books, Redhill, SURRE, United Kingdom
US$ 264.24
Quantity: 1 available
Add to basketPaperback. Condition: Like New. Like New. book.
Language: English
Published by Birkhäuser Basel, Birkhäuser Basel, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.
Language: English
Published by Birkhäuser Basel, Birkhäuser Basel, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 319.41
Quantity: 2 available
Add to basketPaperback. Condition: Brand New. 1999 edition. 268 pages. 9.60x6.69x0.61 inches. In Stock.
Condition: New. pp. x + 251.
Language: English
Published by Birkhauser Verlag AG, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. This monograph contains a description of the discovery and development of a new antisecretory therapy in the treatment of acid-related diseases: omeprazole, the first pump inhibitor. The pharmacology of different proton pump inhibitors and the pharmaceutic delivery system are reviewed. Editor(s): Olbe, Lars. Series: Milestones in Drug Therapy. Num Pages: 261 pages, biography. BIC Classification: MJH; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 244 x 170 x 20. Weight in Grams: 730. . 1999. Hardback. . . . . Books ship from the US and Ireland.
US$ 326.49
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Seller: Mispah books, Redhill, SURRE, United Kingdom
US$ 315.43
Quantity: 1 available
Add to basketHardcover. Condition: Like New. Like New. book.
Condition: As New. Unread book in perfect condition.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Springer, Basel, Birkhäuser Basel Apr 1999, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 251 pp. Englisch.
Language: English
Published by Springer, Basel, Birkhäuser Basel, Birkhäuser Okt 2013, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 251 pp. Englisch.
Seller: Majestic Books, Hounslow, United Kingdom
US$ 270.12
Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 268 51 Illus.
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Proton Pump Inhibitors | Lars Olbe | Buch | Einband - fest (Hardcover) | Englisch | 1999 | Birkhäuser Basel | EAN 9783764358976 | Verantwortliche Person für die EU: Springer Nature c/o IBS, Benzstr. 21, 48619 Heek, tanja[dot]keller[at]springer[dot]com | Anbieter: preigu Print on Demand.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND pp. 268.
Language: English
Published by Birkhäuser Basel, Birkhäuser Basel Apr 1999, 1999
ISBN 10: 3764358971 ISBN 13: 9783764358976
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists. 268 pp. Englisch.
Language: English
Published by Birkhäuser Basel, Birkhäuser Okt 2013, 2013
ISBN 10: 3034897774 ISBN 13: 9783034897778
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 268 pp. Englisch.